[{"address1": "Paasheuvelweg 25", "city": "Amsterdam", "zip": "1105 BP", "country": "Netherlands", "phone": "31 20 240 6000", "website": "https://www.uniqure.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases. It offers HEMGENIX that has completed Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also develops AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease. In addition, it is developing AMT-162, which is in preclinical trial for the treatment of superoxide dismutase 1- amyotrophic lateral sclerosis; AMT-260 that is in preclinical trial to treat temporal lobe epilepsy; AMT-191, which is in preclinical trial for the treatment of fabry disease; AMT-161 that is in preclinical trial to treat amyotrophic lateral sclerosis caused by mutations; AMT-240, which is in preclinical trial to for the treatment of autosomal dominant Alzheimer's disease; and AMT-210 that is in preclinical trial to treat Parkinson's disease. The company was founded in 1998 and is headquartered in Amsterdam, the Netherlands.", "fullTimeEmployees": 480, "companyOfficers": [{"maxAge": 1, "name": "Mr. Matthew Craig Kapusta CPA", "age": 52, "title": "CEO & Executive Director", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 1017357, "exercisedValue": 0, "unexercisedValue": 96250}, {"maxAge": 1, "name": "Mr. Christian  Klemt", "age": 51, "title": "CFO, Principal Financial Officer & GM of Amsterdam Site", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 575462, "exercisedValue": 0, "unexercisedValue": 21000}, {"maxAge": 1, "name": "Mr. Richard  Porter Ph.D.", "age": 55, "title": "Chief Business & Scientific Officer", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 732169, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeannette  Potts J.D., Ph.D.", "age": 62, "title": "Chief Legal & Compliance Officer and Corporate Secretary", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 635561, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Hugo  Katus", "title": "Chairman of Scientific Advisory Board and Managing Director of UniQure-Germany", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Amin  Abujoub Ph.D.", "title": "Chief Technical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tamara  Tugal Ph.D., MBA", "title": "Business Development Director", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erin  Boyer", "title": "Chief People & Culture Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Walid  Abi-Saab M.D.", "age": 59, "title": "Chief Medical Officer", "yearBorn": 1965, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Eileen  Sawyer", "title": "Vice President of Global Medical Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 3, "compensationRisk": 6, "shareHolderRightsRisk": 1, "overallRisk": 3, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 12.96, "open": 12.98, "dayLow": 12.5301, "dayHigh": 13.1499, "regularMarketPreviousClose": 12.96, "regularMarketOpen": 12.98, "regularMarketDayLow": 12.5301, "regularMarketDayHigh": 13.1499, "payoutRatio": 0.0, "beta": 0.384, "forwardPE": -4.1633987, "volume": 496685, "regularMarketVolume": 497542, "averageVolume": 2273515, "averageVolume10days": 837010, "averageDailyVolume10Day": 837010, "bid": 9.35, "ask": 16.17, "bidSize": 2, "askSize": 2, "marketCap": 680792448, "fiftyTwoWeekLow": 3.73, "fiftyTwoWeekHigh": 19.18, "priceToSalesTrailing12Months": 23.852144, "fiftyDayAverage": 15.1847, "twoHundredDayAverage": 8.28115, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 693181120, "profitMargins": 0.0, "floatShares": 39962551, "sharesOutstanding": 53437400, "sharesShort": 3196574, "sharesShortPriorMonth": 3386239, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0598, "heldPercentInsiders": 0.08685, "heldPercentInstitutions": 0.78789, "shortRatio": 2.63, "shortPercentOfFloat": 0.060399998, "impliedSharesOutstanding": 53437400, "bookValue": 1.145, "priceToBook": 11.126637, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -239500992, "trailingEps": -4.95, "forwardEps": -3.06, "enterpriseToRevenue": 24.248, "enterpriseToEbitda": -3.661, "52WeekChange": 1.050633, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 12.76, "targetHighPrice": 70.24173, "targetLowPrice": 19.905817, "targetMeanPrice": 35.691708, "targetMedianPrice": 29.369505, "recommendationKey": "none", "numberOfAnalystOpinions": 10, "totalCash": 435240992, "totalCashPerShare": 8.929, "ebitda": -189319008, "totalDebt": 496711008, "quickRatio": 6.181, "currentRatio": 6.512, "totalRevenue": 28587000, "debtToEquity": 889.828, "revenuePerShare": 0.591, "returnOnAssets": -0.16624, "returnOnEquity": -1.4756501, "grossProfits": -154076000, "freeCashflow": -125178000, "operatingCashflow": -179424992, "revenueGrowth": 0.625, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -17.769129, "financialCurrency": "USD", "symbol": "QURE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NMS", "messageBoardId": "finmb_171029664", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.6975329, "regularMarketPrice": 12.74, "marketState": "REGULAR", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1391610600000, "regularMarketChange": -0.22000027, "regularMarketDayRange": "12.5301 - 13.1499", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2273515, "fiftyTwoWeekLowChange": 9.01, "fiftyTwoWeekLowChangePercent": 2.4155498, "fiftyTwoWeekRange": "3.73 - 19.18", "fiftyTwoWeekHighChange": -6.4400005, "fiftyTwoWeekHighChangePercent": -0.33576643, "fiftyTwoWeekChangePercent": 105.06329, "earningsTimestampStart": 1740398700, "earningsTimestampEnd": 1740830700, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.95, "epsForward": -3.06, "epsCurrentYear": -3.72612, "priceEpsCurrentYear": -3.4191062, "fiftyDayAverageChange": -2.4447002, "fiftyDayAverageChangePercent": -0.1609976, "twoHundredDayAverageChange": 4.45885, "twoHundredDayAverageChangePercent": 0.5384337, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "corporateActions": [], "regularMarketTime": 1740170673, "shortName": "uniQure N.V.", "longName": "uniQure N.V.", "displayName": "uniQure", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]